Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Bliss GVS Pharma Ltd

BLISSGVS.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Small Cap Analyst: N/A

Last Close

$5.44

▲ +1.02%

Market Cap $578.20M · Vol 390.44K

Key Metrics

P/E Ratio

41.18

FWD: N/A

Market Cap

$578.20M

Small Cap

Div Yield

0.29%

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

73.37

Momentum

Beta

0.91

vs Market

52W High

$5.79

6.87% below

52W Low

$1.24

308.86% above

Volume

390.44K

Avg 334.95K

P/B

1.91

Price-to-book

ROE

N/A

Return on equity

Free Float

42.50%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Bliss GVS Pharma Ltd (BLISSGVS.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BLISSGVS.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+8.73%

-0.36%

+79.42%

+138.38%

YTD

+217.80%

+206.63%

+390.77%

+364.03%

Financials & Valuation

TTM · Annual

Total Revenue	$99.20M
Net Income	$14.42M
Revenue Growth (YoY)	+37.65%
Gross Margin	49.01%
Operating Margin	14.52%
Net Profit Margin	14.53%
ROE	N/A
ROA · ROIC	13.57% · 10.83%

P/E Ratio	41.18
Forward P/E (FY1)	N/A
PEG Ratio	0.35
P/S	2.50
P/B	1.91
P/FCF	27.64
EPS Growth	N/A
Outstanding Shares	106.28M

Technical Indicators

50-Day SMA	$5.05
200-Day SMA	$2.93
RSI (14)	73.37
Beta	0.91
52-Week High	$5.79
52-Week Low	$1.24

Volume Today	390.44K
Avg Daily Volume (30D)	334.95K
Relative Volume	1.17x
Volatility (10D)	38.71
Volatility (30D)	38.59
Free Float	42.50%

Analyst Consensus

N/A

Current Price $5.44

Mean Target N/A

52W Low$1.24 52W High$5.79

Current

Target

$1.24 $5.79

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S82ZM5

ISININE416D01022

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd -0.10% 4578.T Otsuka Holdings Co Ltd -3.26% CIPLA.NS Cipla Ltd -0.60% ZYDUSLIFE.NS Zydus Lifesciences Ltd -2.75% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +1.56%

Company Profile

Bliss GVS Pharma Limited is engaged in developing, manufacturing, and marketing pharmaceutical formulations. The Company’s product categories include pharma products, other healthcare products, and therapeutic index. Its pharma products include pharma products include capsules, creams, gels, ointments, dry powder for injection, effervescent tablets, eye/ear drops, nasal solution, lotions, lozenges, oral solids, and others. The Company’s other healthcare products include balm, nasal inhaler, solution, soap, roll on, shampoo, powder, spray, and petroleum jelly. Its brands include ANOMEX, ANOMEX DS, CONLAX 5/10, G - ALFENAC 100, GACET 80/125/170/250/500/1G, GMETH - 50/100, GSUNATE - 50/100/200, GVCAM - 7.5/15, GV-SOFT 1/2/3/4 G, LOFNAC - 12.5/25/50/100, MEFINOL, MELANEZ, MENINA - 25/100, TYRIDOL, VIGOTAMIN, COMIT 50, BG - CLIND, VAGID CL, ECOZOLE, GVGYL 500, GYNANFORT, GVGYL N, KLOVINAL, LONART, LONART FORTE, LONART Dispersible, FINMOL, GACET-500, NOVOGLIP-5, GVZOLE, and DOXYCYCLINE.